v3.25.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:                
Net income (loss) $ (393,970) $ (2,039,997) $ 825,358 $ 786,362 $ (1,683,664)   $ 2,428,474  
Adjustments to reconcile net income (loss) to net cash used in operating activities:                
Income earned on investment held in Trust Account (85,725)   (952,787)   (271,452)   (2,818,129)  
Amortized interest expense from debt discount         122,174    
Loss on issuance of FPA liability     1,929,656    
Change in fair value of FPA liability 367,148     (756,006) $ (756,005)  
Financing expense     336,000    
Changes in current assets and liabilities:                
Accrued offering costs and expenses         120,313   160,094  
Accrued expenses - related party         96,271   40,445  
Prepaid Expenses         20,665   34,050  
Net cash used in operating activities         (86,043)   (155,066)  
Cash flows from investing activities:                
Cash withdrawn from trust account in connection with redemption         67,850,462    
Net cash provided by investing activities         67,850,462    
Cash flows from financing activities:                
Payment of public shareholders’ redemption         (67,850,462)    
Net cash used in financing activities         (67,850,462)    
Net change in cash and cash equivalents         (86,043)   (155,066)  
Cash and cash equivalents at beginning of period   103,774   $ 426,913 103,774   426,913 $ 426,913
Cash and cash equivalents at the end of period 17,731   $ 271,847   17,731 $ 17,731 271,847 103,774
Supplemental disclosure of noncash financing activities                
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) $ (186,054) $ 97,321     271,452   2,818,129 $ 3,684,883
Offering cost paid by target company           $ 75,000